Inventor · disambiguated record
Samuel Kaye Reznik
Also filed as: REZNIK SAMUEL K · REZNIK SAMUEL KAYE
7 granted patents·9 pending applications·4 citations·filing 2017–2024
73Inventor score
Files withBRISTOL MYERS SQUIBB CO4RECLUDIX PHARMA INC3LES LABORATOIRES SERVIER SAS2SERVIER LAB2UNIV MONTREAL2
Top patents by PatentIndex Score
16 records- 0182US11932658B2Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Mar 19, 2024·1 cites·19 claims
- 0279US11524960B2Heterobicyclic inhibitors of MAT2A and methods of use for treating cancerAGIOS PHARMACEUTICALS INC·Filed 2019·Granted Dec 13, 2022·2 cites·44 claims
- 0372US2025214988A1Heterobicyclic inhibitors of mat2a and methods of use for treating cancerSERVIER LAB·Filed 2024·Application pending·0 cites
- 0471US10730868B2Bicyclic heteroaryl substituted compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 4, 2020·1 cites·14 claims
- 0568US12037324B2Biarylmethyl heterocyclesUNIV MONTREAL·Filed 2022·Granted Jul 16, 2024·0 cites·17 claims
- 0661US2025215030A1Stat modulators and uses thereofRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
- 0760US2025215029A1Stat modulators and uses thereofRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
- 0859US12060347B2Bicyclic heteroaryl substituted compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Aug 13, 2024·0 cites·33 claims
- 0958US2025179103A16-oxodecahydropyrrolo[1,2-a][1,5]diazocine and 6-oxodecahydro-4h-pyrrolo[2,1-d][1,5]thiazocine derivatives as stat3 and stat6 modulators for the treatment of cancer and inflammatory conditionsRECLUDIX PHARMA INC·Filed 2023·Application pending·0 cites
- 1056US2019315774A1Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 1154US12077534B2Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancerLES LABORATOIRES SERVIER SAS·Filed 2019·Granted Sep 3, 2024·0 cites·35 claims
- 1254US11407733B2Biarylmethyl heterocyclesUNIV MONTREAL·Filed 2017·Granted Aug 9, 2022·0 cites·14 claims
- 1352US2022169654A1New Organic CompoundsSERVIER PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1448US2022251081A1Heterobicyclic inhibitors of mat2a and methods of use for treating cancerSERVIER LAB·Filed 2020·Application pending·0 cites
- 1545US2022098203A1Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancerLES LABORATOIRES SERVIER SAS·Filed 2019·Application pending·0 cites
- 1641US2019292176A1Bicyclic heteroaryl substituted compoundsBISTOL MYERS SQUIBB COMPANY·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Samuel Kaye Reznik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →